Skip to main content
. Author manuscript; available in PMC: 2014 Aug 6.
Published in final edited form as: Pharm Res. 2009 May 5;26(7):1752–1763. doi: 10.1007/s11095-009-9886-2

Fig. 4.

Fig. 4

The percent of paclitaxel and cisplatin in F1 combination nanoparticle agglomerate formulation deposited on the stages of a cascade impactor at a flow rate of ~30 L/min.